Nano-hydroxyapatite is a biomimetic material that closely matches the size, structure, and composition of natural enamel crystals, making it well-suited to interact with the oral environment. A substantial body of research supports its role in remineralization, enamel strengthening, and dentin hypersensitivity reduction through mechanisms including ion release, crystal growth, and tubule occlusion. Safety evaluations, including review by the European Scientific Committee on Consumer Safety (SCCS), have found nano-hydroxyapatite to be safe for use in oral care products within defined parameters, with no evidence of genotoxicity and minimal systemic exposure. Importantly, its clinical performance is not determined by the ingredient alone, but by how it is formulated. Factors such as particle size, morphology, stability, and interaction with saliva and biofilm all influence its ability to function effectively in the dynamic oral environment.
Explore the Science
View Full Technical Response
A detailed, referenced review of nano-hydroxyapatite by Dr. Kim Kutsch, including biology, safety, and mechanism.
Formulation Matters
Why formulation determines how nano-hydroxyapatite performs in the oral environment.
Clinical outcomes are not determined by ingredients alone. Particle size, morphology, stability and interaction with the oral environment all influence how nano-hydroxyapatite performs. Our work with nano hydroxyapatite dates back to 2012. With over a decade of formulation experience, our focus has been understanding how it behaves in the oral environment and how formulation determines clinical performance.
Formulation in Practice
What does this look like in a real formulation?
Formulation determines whether nano-hydroxyapatite functions as intended. This is one example of how those principles are applied in practice.
CariFree Pro Gel 5000 is a clinically designed formulation combining 1.1% fluoride, medical-grade nano-hydroxyapatite, and a unique pH buffering technology.
View our professional product profile to learn more.
About Dr. Kutsch
Dr. Kim Kutsch is a clinician, innovator, and educator with over 40 years of experience in dentistry, with a focus on minimally invasive care and remineralization strategies. He earned his DMD from the University of Oregon School of Dentistry and holds an undergraduate degree from Westminster College.
Dr. Kutsch holds 17 patents related to oral care technologies and has authored over 100 articles and multiple textbook chapters. He has presented internationally and has served in leadership roles with organizations including the Academy of Laser Dentistry and the World Congress of Minimally Invasive Dentistry.
He is a Graduate, Mentor, and Scientific Advisor in Dental Caries at the Kois Center and serves as a reviewer for journals such as the Journal of the American Dental Association.
As CEO of Oral BioTech, the makers of CariFree, Dr. Kutsch focuses on developing formulations that align with the biology of the oral environment and translating scientific principles into clinically relevant solutions.